The Opioid Hydra: Understanding Overdose Mortality Epidemics and Syndemics Across the Rural-Urban Continuum.

David J Peters, Shannon M Monnat, Andrew L Hochstetler, Mark T Berg
Author Information
  1. David J Peters: Department of Sociology, Iowa State University.
  2. Shannon M Monnat: Maxwell School of Citizenship and Public Affairs, Syracuse University.
  3. Andrew L Hochstetler: Department of Sociology, Iowa State University.
  4. Mark T Berg: Department of Sociology and Criminology, University of Iowa.

Abstract

The rapid increase of fatal opioid overdoses over the past two decades is a major U.S. public health problem, especially in non-metropolitan communities. The crisis has transitioned from pharmaceuticals to illicit synthetic opioids and street mixtures, especially in urban areas. Using latent profile analysis, we classify = 3,079 counties into distinct classes using CDC fatal overdose rates for specific opioids in 2002-2004, 2008-2012, and 2014-2016. We identify three distinct epidemics (prescription opioids, heroin, and prescription-synthetic opioid mixtures) and one syndemic involving all opioids. We find that prescription-related epidemic counties, whether rural or urban, have been "left behind" the rest of the nation. These communities are less populated and more remote, older and mostly white, have a history of drug abuse, and are former farm and factory communities that have been in decline since the 1990s. Overdoses in these places exemplify the "deaths of despair" narrative. By contrast, heroin and opioid syndemic counties tend to be more urban, connected to interstates, ethnically diverse, and in general more economically secure. The urban opioid crisis follows the path of previous drug epidemics, affecting a disadvantaged subpopulation that has been left behind rather than the entire community. County data on opioid epidemic class membership are provided.

References

Urban Aff Rev Thousand Oaks Calif. 2008;43(6):846-874 [PMID: 19655037]
Am J Public Health. 2014 Feb;104(2):e52-9 [PMID: 24328642]
J Health Econ. 2019 Mar;64:25-42 [PMID: 30784811]
Am J Prev Med. 2018 May;54(5):611-619 [PMID: 29598858]
Addiction. 2018 Jul;113(7):1339-1344 [PMID: 29430760]
Int J Drug Policy. 2015 May;26(5):484-91 [PMID: 25458403]
MMWR Morb Mortal Wkly Rep. 2018 Jan 04;67(5152):1419-1427 [PMID: 30605448]
Soc Sci Res. 2013 Nov;42(6):1490-504 [PMID: 24090847]
J Health Econ. 2017 Dec;56:222-233 [PMID: 29128677]
Lancet. 2017 Mar 4;389(10072):941-950 [PMID: 28271845]
AJS. 2009 Jan;114(4):1037-101 [PMID: 19824301]
Am J Prev Med. 2017 Apr;52(4):469-475 [PMID: 27856114]
Int J Drug Policy. 2019 Sep;71:183-188 [PMID: 30718120]
Am J Public Health. 2018 Feb;108(2):182-186 [PMID: 29267060]
Am J Prev Med. 2017 Dec;53(6):745-753 [PMID: 28797652]
Am J Public Health. 2019 Aug;109(8):1084-1091 [PMID: 31219718]
JAMA. 2015 Mar 3;313(9):891-2 [PMID: 25622279]
Int J Drug Policy. 2016 Mar;29:19-26 [PMID: 26868674]
Brookings Pap Econ Act. 2017 Spring;2017:397-476 [PMID: 29033460]
Inj Prev. 2015 Feb;21(1):35-41 [PMID: 25024394]
Drug Alcohol Depend. 2014 Dec 1;145:34-47 [PMID: 25454406]
Struct Equ Modeling. 2013 Jan;20(1):1-26 [PMID: 25419096]
Health Serv Res. 2018 Dec;53(6):4310-4331 [PMID: 29845634]
Int J Drug Policy. 2018 Jul;57:119-129 [PMID: 29754032]
J Urban Health. 2003 Dec;80(4 Suppl 3):iii50-8 [PMID: 14713671]
BMC Public Health. 2016 Feb 03;16:115 [PMID: 26847554]
Brookings Pap Econ Act. 2017 Fall;2017(2):1-87 [PMID: 30739945]
Science. 2018 Sep 21;361(6408): [PMID: 30237320]
Science. 1997 Aug 15;277(5328):918-24 [PMID: 9252316]
J Rural Health. 2016 Spring;32(2):204-18 [PMID: 26344571]
MMWR Morb Mortal Wkly Rep. 2007 Feb 9;56(5):93-6 [PMID: 17287712]
Am J Agric Econ. 2018 Oct;100(5):1357-1374 [PMID: 30344331]

Grants

  1. P2C HD041025/NICHD NIH HHS
  2. R24 AG045061/NIA NIH HHS
  3. R24 AG065159/NIA NIH HHS

Word Cloud

Similar Articles

Cited By